Evli Japan vs SEB Bioteknikfond D

Evli Japan vs SEB Bioteknikfond D

1. Evli Japan

  • Security

    Evli Japan

  • Fee

    1.62%

  • ISIN

    FI0008807722

  • Holdings

    1

2. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

Fund Holdings

We have information about 2 holdings in Evli Japan, where the largest holding is Inpex (2.05), followed by (0) and (0). In comparison with SEB Bioteknikfond D, we have 24 holdings where Gilead Sciences is the largest holding (10.04), followed by Vertex (8.8) and Amgen (8.54).

All Holdings

Here we compare the holdings in Evli Japan and SEB Bioteknikfond D.

Evli Japan SEB Bioteknikfond D
1. Inpex Corp
Japan
2.05 %
1. Gilead Sciences Inc
USA
10.04 %
- 2. Vertex Pharmaceuticals Inc
8.8 %
- 3. Amgen Inc
USA
8.54 %
- 4. Regeneron Pharmaceuticals Inc
5.09 %
- 5. Alnylam Pharmaceuticals Inc
5.07 %
- 6. AstraZeneca ADR
Sweden UK
4.49 %
- 7. Verona Pharma ADR
3.46 %
- 8. Argenx ADR
2.72 %
- 9. Illumina Inc
2.72 %
- 10. BioNTech SE
2.41 %
- 11. Madrigal Pharmaceuticals Inc
1.88 %
- 12. BoneSupport AB
Sweden
1.82 %
- 13. BioMarin Pharmaceutical Inc
1.7 %
- 14. Krystal Biotech Inc
1.48 %
- 15. NewAmsterdam Pharma NV
1.46 %
- 16. BridgeBio Pharma Inc
1.45 %
- 17. Cytokinetics Inc
1.4 %
- 18. Ionis Pharmaceuticals Inc
1.37 %
- 19. Xenon Pharmaceuticals
1.37 %
- 20. Insmed Inc
1.32 %
- 21. Onward Medical NV
1.31 %
- 22. Janux Therapeutics Inc
1.3 %
- 23. Structure Therapeutics ADR
1.24 %
- 24. Kymera Therapeutics Inc
1.09 %

The list of fund holdings was last updated on September 10, 2025.